Dolin R, Graham BS, Greenberg SB, Tacket CO, Belshe RB, Midthun K, Clements ML, Gorse GJ, Horgan BW, Atmar RL, et al. The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network. Ann Intern Med. 1991 Jan 15;114(2):119-27.

Also known as
  • Add other possible names for this topic
Edit
There is no user-contributed description yet.

Add description

Contents:
With the exception of Wikipedia summaries and some images the content on this page is typically distributed under the Creative Commons Attribution license or Public Domain.

Topic History
Created by shmandrea Apr 24, 2008
Last edited by shmandrea Apr 24, 2008
Gallery add an image edit gallery
There are no images for this topic yet.
There are no weblinks for this topic yet.

Recent Discussions about Dolin R, Graham BS, Greenberg SB, Tacket CO, Belshe RB, Midthun K, Clements ML, Gorse GJ, Horgan BW, Atmar RL, et al. The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network. Ann Intern Med. 1991 Jan 15;114(2):119-27.

There are no conversations on this topic. Would you like to start one?

Start the Discussion